Tau Exon 10 inclusion by PrPC through downregulating GSK3β activity

dc.contributor.authorLidón Gil, Laia
dc.contributor.authorLlaó-Hierro, Laura
dc.contributor.authorNuvolone, Mario
dc.contributor.authorAguzzi, Adriano
dc.contributor.authorÁvila, Jesús
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)
dc.contributor.authorRío Fernández, José Antonio del
dc.contributor.authorGavín Marín, Rosalina
dc.date.accessioned2021-10-06T15:00:31Z
dc.date.available2021-10-06T15:00:31Z
dc.date.issued2021-05-20
dc.date.updated2021-10-06T15:00:32Z
dc.description.abstractTau protein is largely responsible for tauopathies, including Alzheimer's disease (AD),where it accumulates in the brain as insoluble aggregates. Tau mRNA is regulated by alternativesplicing, and inclusion or exclusion of exon 10 gives rise to the 3R and 4R isoforms respectively, whosebalance is physiologically regulated. In this sense, one of the several factors that regulate alternativesplicing of tau is GSK3β, whose activity is inhibited by the cellular prion protein (PrPC), whichhas different physiological functions in neuroprotection and neuronal differentiation. Moreover, arelationship between PrPCand tau expression levels has been reported during AD evolution. Forthis reason, in this study we aimed to analyze the role of PrPCand the implication of GSK3βin theregulation of tau exon 10 alternative splicing. We used AD human samples and mouse models ofPrPCablation and tau overexpression. In addition, we used primary neuronal cultures to developfunctional studies. Our results revealed a paralleled association between PrPCexpression and tau4R isoforms in all models analyzed. In this sense, reduction or ablation of PrPClevels induces anincrease in tau 3R/4R balance. More relevantly, our data points to GSK3βactivity downstream fromPrPCin this phenomenon. Our results indicate that PrPCplays a role in tau exon 10 inclusion throughthe inhibitory capacity of GSK3β.
dc.format.extent24 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec713495
dc.identifier.issn1661-6596
dc.identifier.urihttps://hdl.handle.net/2445/180457
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ijms22105370
dc.relation.ispartofInternational Journal of Molecular Sciences, 2021, vol. 22, num. 10, p. 1-24
dc.relation.urihttps://doi.org/10.3390/ijms22105370
dc.rightscc-by (c) Lidón Gil, Laia et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Biologia Cel·lular, Fisiologia i Immunologia)
dc.subject.classificationMalalties neurodegeneratives
dc.subject.classificationMalaltia d'Alzheimer
dc.subject.classificationMicrotúbuls
dc.subject.otherNeurodegenerative Diseases
dc.subject.otherAlzheimer's disease
dc.subject.otherMicrotubules
dc.titleTau Exon 10 inclusion by PrPC through downregulating GSK3β activity
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
713495.pdf
Mida:
3.91 MB
Format:
Adobe Portable Document Format